ResearcherJohns Hopkins UniversityActive in the last 2 years
Amol Gupta
Matched on ORCID iD 0000-0001-8307-4192; OpenAlex author ID A5068534427. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2023: 1 paper · 2024: 1 paper
Papers 2
- Clinical outcomes of liposomal irinotecan in patients with advanced pancreatic cancer previously treated with conventional irinotecan: A meta-analysis of real-… Co-author DOI 10.1002/cncr.35479↗
- Clinical outcomes of liposomal irinotecan in advanced pancreatic adenocarcinoma patients previously treated with conventional irinotecan-based chemotherapy: a … Co-author DOI 10.3389/fonc.2023.1250136↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Dung Thi Le · 2 shared papers, 2023–2024 · strength 0.43
- Paper Clinical outcomes of liposomal irinotecan in patients with advanced pancreatic cancer previously treated with conventio… DOI 10.1002/cncr.35479↗
- Paper Clinical outcomes of liposomal irinotecan in advanced pancreatic adenocarcinoma patients previously treated with conven… DOI 10.3389/fonc.2023.1250136↗
- Ana De Jesus‐Acosta · 2 shared papers, 2023–2024 · strength 0.43
- Paper Clinical outcomes of liposomal irinotecan in patients with advanced pancreatic cancer previously treated with conventio… DOI 10.1002/cncr.35479↗
- Paper Clinical outcomes of liposomal irinotecan in advanced pancreatic adenocarcinoma patients previously treated with conven… DOI 10.3389/fonc.2023.1250136↗
- Michael Jon Pishvaian · 2 shared papers, 2023–2024 · strength 0.43
- Paper Clinical outcomes of liposomal irinotecan in patients with advanced pancreatic cancer previously treated with conventio… DOI 10.1002/cncr.35479↗
- Paper Clinical outcomes of liposomal irinotecan in advanced pancreatic adenocarcinoma patients previously treated with conven… DOI 10.3389/fonc.2023.1250136↗
- Daniel A. Laheru · 2 shared papers, 2023–2024 · strength 0.43
- Paper Clinical outcomes of liposomal irinotecan in patients with advanced pancreatic cancer previously treated with conventio… DOI 10.1002/cncr.35479↗
- Paper Clinical outcomes of liposomal irinotecan in advanced pancreatic adenocarcinoma patients previously treated with conven… DOI 10.3389/fonc.2023.1250136↗
- Lei Zheng · 1 shared paper, 2024 · strength 0.24
- Neeha Zaidi · 1 shared paper, 2024 · strength 0.24
- Valerie Lee · 1 shared paper, 2023 · strength 0.19
- Ihab R. Kamel · 1 shared paper, 2023 · strength 0.19
- Lei Zheng · 1 shared paper, 2023 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.